Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19
Clinical trial NCT04428801 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04428801
- Sponsor
- Celltex Therapeutics Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.